GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEMIS.L Share News (EMIS)

  • There is currently no data for EMIS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Jersey Oil in talks with North Sea "heavyweight"

Fri, 31st Mar 2023 11:06

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Jersey Oil & Gas PLC, up 33% at 202.5 pence, 12-month range 146p-357p. The upstream oil and gas company updates on the Greater Buchan Area farm-out process, revealing it is in "advanced" exclusive discussions with an unnamed "significant" UK North Sea operator. Says head of terms have been agreed for the farm-out of a material interest in the GBA licenses to the operator, and the parties are working towards a finalised fully-termed agreement "in the near future". They have agreed to an exclusivity period until the end of April. "We are pleased to be in advanced exclusive negotiations with a well-funded industry heavyweight and whilst there can be no guarantees of a successful conclusion, we are aiming to finalise the farm-out in the near future and look forward to updating shareholders shortly," says CEO Andrew Benitz.

----------

AIM - LOSERS

----------

Shearwater Group PLC, down 38% at 51.9p, 12-month range 40p-155p. The cybersecurity group warns its performance in the year ending Friday is likely to disappoint and be "significantly behind market expectations". Expects annual revenue of GBP27.0 million, compared to GBP35.9 million a year before and market consensus of GBP37.7 million. Adjusted earnings before interest, tax, depreciation and amortisation are expected at "around breakeven", compared to market consensus that it would remain unchanged from the GBP4.4 million achieved in the prior year. The weaker performance reflects delays in finalisation of orders in Services and Software businesses, as customers defer investment decisions or implement spending freezes amid market volatility in the final quarter. "Looking forward the group retains a strong pipeline on which to deliver sustainable revenue, with profits moving forward as we deliver deals to our loyal customer base, including banks and telecoms businesses," Shearwater says.

----------

Asimilar Group PLC, down 33% at 1.40p, 12-month range 1.3p-30p. The technology investor says it will suspend its shares from trading on AIM and AQSE from Monday, as it will fail to meet the reporting deadline for its audited annual results for the year ended September 30. "The board has been working hard with the auditor to clear all outstanding issues, however, the auditor requires additional time to complete all audit formalities," it says. The delay is partly due to an "exhaustive" review process of independent third-party valuations on some of the firm's unquoted investee companies.

----------

Emis Group PLC, down 24% at 1,376p, 12-month range 1,242p-1,918p. The healthcare software firm falls on news that the UK competition watchdog has referred its acquisition by US healthcare insurer UnitedHealth to a phase 2 investigation. Earlier this month, as part of its phase 1 probe, the UK Competition & Markets Authority found competition in the fields of population health management and medicines optimisation software would be hurt by the deal. Both Emis and UnitedHealth-owned Optum Health Solutions (UK) provide software services to GPs in the UK. In response, UnitedHealth proposed a remedy to divest of Optum's Medicines Optimisation and Population Health Management businesses in the UK. The CMA rejected the remedy, and confirmed it would refer the acquisition for a phase 2 investigation. Emis and UnitedHealth say they are "disappointed" with the decision, believing the divestment would directly address the CMA's competition concerns.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Aug 2018 16:17

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 27 August no events scheduled Tuesday 28 PartnerTrading Year Year 29

Read more
29 Jun 2018 13:36

DIRECTOR DEALINGS: EMIS CEO Buys GBP200,860 Worth Of Shares

LONDON (Alliance News) - Healthcare software company EMIS Group PLC said Chief Executive Officer Andrew Thorburn purchased 22,445 shares at an aggregate price of 894.9 pence per share on has not

Read more
24 Apr 2018 16:19

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 25 AprilDrax GroupBritish American TobaccoCLS HoldingsCroda Investment 26 1

Read more
14 Mar 2018 09:07

EMIS Profit Drops By More Than Half In 2017 Amid Service Level Charges

LONDON (Alliance News) - EMIS Group PLC said on Wednesday that despite slight revenue growth, profit was cut in half in 2017 by a one-off service reporting charge and costs at

Read more
7 Mar 2018 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday March 8 G4SFull Year ResultsAvivaFull Year Year Year EnterprisesHalf 9

Read more
26 Jan 2017 11:31

Emis Group in line with expectations despite NHS funding headwinds

(ShareCast News) - Shares fell in Emis Group as the healthcare software firm reported that its performance was in line with expectations despite headwinds created by the gap in NHS funding, as the company accelerates it implementation plan. Due to pending changes in NHS models of care, Emis Group de

Read more
12 Dec 2016 11:57

Emis CEO to retire next year

(ShareCast News) - Emis Group, an AIM listed healthcare software and services provider, announced that its chief executive Chris Spencer has decided to go into retirement by the end of 2017. The company has begun a formal search to find a suitable replacement. Spencer has served as CEO from 2013 bu

Read more
8 Nov 2016 08:25

LONDON BRIEFING: AB Foods Leads Gainers In Nervous Market

Read more
2 Sep 2016 11:09

EMIS' revenue rises as it remains confident about NHS investment despite Brexit uncertainity

(ShareCast News) - EMIS's revenues rose as it maintained that despite political and economic uncertainty, in light of the Brexit vote, it is encouraged by NHS investment. The AIM-listed healthcare software provider said it was performing broadly in line with expectations for the first half of the ye

Read more
14 Jul 2016 07:15

EMIS Trading Broadly In Line And Full Year Expectations Unchanged

Read more
8 Jul 2016 15:00

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Apr 2016 08:15

EMIS Trading In Line In 2016 With New Contracts Won Across Business

Read more
25 Apr 2016 15:07

Dividends Calendar - Week Ahead

Read more
22 Apr 2016 15:07

Dividends Calendar - Week Ahead

Read more
19 Apr 2016 15:03

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.